Federated Hermes
TNYA icon

Federated Hermes’s Tenaya Therapeutics TNYA Stock Holding History

Federated Hermes’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,709
Closed -$2.27K – 2230
2025
Q2 		$2.27K Hold
3,709
– – ﹤0.01% 1950
2025
Q1 		$2.12K Buy
+3,709
New +$3.66K ﹤0.01% 1945
2024
Q3 		– Sell
-414
Closed -$1.28K – 2163
2024
Q2 		$1.28K Buy
414
+413
+41,300% +$1.71K ﹤0.01% 1937
2024
Q1 		$5 Buy
+1
New +$5 ﹤0.01% 2016
2023
Q3 		– Sell
-166
Closed -$974 – 2198
2023
Q2 		$974 Buy
+166
New +$965 ﹤0.01% 2026

Other funds holding TNYA

CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Federated Hermes's TNYA Position: Q3 2025 in Review

Federated Hermes sold out of Tenaya Therapeutics (TNYA) in Q3 2025, closing a stake of 3,709 shares — an estimated $2.27K sold.

Federated Hermes first reported a position in TNYA in Q2 2023 and held it in 5 quarters. The position peaked at $2.27K in Q2 2025. 91 funds tracked by Wall St. Rank hold TNYA as of Q3 2025.

  • Federated Hermes reported no remaining Tenaya Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Federated Hermes sold 3,709 Tenaya Therapeutics shares in Q3 2025, an estimated $2.27K.
  • Federated Hermes first reported a position in Tenaya Therapeutics in Q2 2023 and held it in 5 quarters.
  • Federated Hermes's Tenaya Therapeutics position peaked at $2.27K in Q2 2025.
  • 91 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2025.

Based on Federated Hermes's 13F filing for Q3 2025, filed 3 Nov 2025.